Prestige Consumer Healthcare Newsroom

Trump Says 'Major Tariff on Pharmaceuticals' Coming Soon

Seeking AlphaApr 9 01:45 ET

Smile in Strides: Goody's Pain Relief Encourages Runners to Harness the Power of a Simple Smile to Reduce Pain and Boost Performance

PR NewswireApr 8 11:02 ET

Beyond The Numbers: 4 Analysts Discuss Prestige Consumer Stock

BenzingaMar 21 17:00 ET

Correction to Premium Brands Holdings Rating

Dow JonesMar 21 13:43 ET · Ratings

CORRECTION: RBC Capital Maintains Sector Perform on Premium Brands Hldgs, Raises Price Target to C$97 (Stock Name Change From Prestige Consumer (NYSE:PBH) To (TSX: PBH) Premium Brands Holdings.

BenzingaMar 21 12:51 ET · Ratings

Express News | CORRECTION: RBC Capital Maintains Sector Perform on Premium Brands Hldgs, Raises Price Target to C$97 (Stock Name Change From Prestige Consumer (NYSE:PBH) To (TSX: PBH) Premium Brands Holdings

BenzingaMar 21 12:51 ET

Express News | RBC Capital Maintains Sector Perform on Prestige Consumer, Raises Price Target to $97

BenzingaMar 21 12:35 ET

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Simply Wall StMar 21 10:50 ET

Earnings Scheduled For March 21, 2025

BenzingaMar 21 04:32 ET

The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.

Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.

Zhitong FinanceMar 18 03:00 ET

New York Manufacturing Hits Low, Inflation Fears Rise

InvestingMar 17 08:50 ET

Top Executive Sells Thousands of Prestige Consumer Healthcare Shares!

TipRanksMar 5 21:16 ET

William Blair Initiates Prestige Consumer Healthcare(PBH.US) With Buy Rating

Moomoo NewsMar 3 06:31 ET · Ratings

Prestige Consumer Healthcare: Undervalued Growth Potential With Strong Financial Performance and Shareholder Return Prospects

TipRanksMar 3 06:19 ET

Investing in Prestige Consumer Healthcare (NYSE:PBH) Five Years Ago Would Have Delivered You a 116% Gain

Simply Wall StFeb 28 08:47 ET

Prestige Consumer Healthcare Insider Sold Shares Worth $959,271, According to a Recent SEC Filing

MT NewswiresFeb 13 16:23 ET

Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $93

Moomoo NewsFeb 13 08:31 ET · Ratings

Express News | Prestige Consumer Healthcare Inc : Oppenheimer Raises Target Price to $93 From $87

ReutersFeb 13 00:39 ET

Eye Drops and Lubricants Market Report 2025-2033, With Profiles of Alcon, Allergan, Bayer, Maya Biotech, Prestige Consumer Healthcare, Rohto Pharmaceutical, Sager Pharma, Similasan & More

Yahoo FinanceFeb 10 13:02 ET

D.A. Davidson Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $104

Moomoo NewsFeb 10 08:31 ET · Ratings